ADAMTS13 and thrombotic thrombocytopenic purpura: The primary objective was to report ADAMTS-13 enzymatic activity levels and distribution in categories: severe deficiency <10% (TTP diagnosis), borderline activity 10-20%, and no deficiency >20%.